- Home
- LNTH vs ATAT Comparison
LNTH vs ATAT Comparison
Compare LNTH & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | ATAT |
|---|---|---|
| Founded | 1956 | 2013 |
| Country | United States | China |
| Employees | 808 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.1B |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | LNTH | ATAT |
|---|---|---|
| Price | $68.85 | $39.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $78.00 | $46.16 |
| AVG Volume (30 Days) | 724.7K | ★ 1.3M |
| Earning Date | 02-26-2026 | 03-24-2026 |
| Dividend Yield | N/A | ★ 1.15% |
| EPS Growth | N/A | ★ 25.36 |
| EPS | ★ 2.39 | 1.48 |
| Revenue | ★ $1,525,933,000.00 | $1,276,315,178.00 |
| Revenue This Year | $0.01 | $37.76 |
| Revenue Next Year | $0.26 | $24.20 |
| P/E Ratio | $28.99 | ★ $26.48 |
| Revenue Growth | 1.95 | ★ 36.24 |
| 52 Week Low | $47.25 | $21.50 |
| 52 Week High | $111.29 | $43.17 |
Technical Indicators
Market Signals| Indicator | LNTH | ATAT |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 53.86 |
| Support Level | $64.52 | $38.40 |
| Resistance Level | $68.70 | $40.25 |
| Average True Range (ATR) | 2.26 | 1.53 |
| MACD | 0.19 | 0.47 |
| Stochastic Oscillator | 91.37 | 80.99 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.